NORTHERN TECHNOLOGIES INTERNATIONAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NORTHERN TECHNOLOGIES INTERNATIONAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $84.23M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $85.06M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $79.90M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $74.16M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $56.49M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $47.64M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $55.75M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $51.42M | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $39.57M | Nov 13, 2018 |
| FY2013 | Aug 31, 2012 | $5.17M | Nov 22, 2013 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Aug 31, 2017 | $39.57M | Nov 21, 2017 |
| FY2017 | Aug 31, 2016 | $32.93M | Nov 21, 2017 |
| FY2015 | Aug 31, 2015 | $8.10M | Nov 13, 2015 |
| FY2015 | May 31, 2015 | $8.28M | Nov 13, 2015 |
| FY2015 | Feb 28, 2015 | $6.73M | Nov 13, 2015 |
| FY2015 | Nov 30, 2014 | $7.21M | Nov 13, 2015 |
| FY2015 | Aug 31, 2014 | $7.38M | Nov 13, 2015 |
| FY2015 | May 31, 2014 | $6.92M | Nov 13, 2015 |
| FY2015 | Feb 28, 2014 | $6.22M | Nov 13, 2015 |
| FY2015 | Nov 30, 2013 | $6.31M | Nov 13, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $31.68M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $33.79M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $27.80M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $23.07M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $19.57M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $16.03M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $17.78M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $17.26M | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $13.25M | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | $10.61M | Nov 21, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $17.6K | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $5.41M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $2.91M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $6.32M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $6.28M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | ($1.34M) | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $5.21M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $6.70M | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $3.42M | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | ($867.5K) | Nov 21, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.57M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $7.87M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $6.02M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $5.15M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $8.32M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $1.59M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $6.59M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $8.02M | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $4.60M | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | $1.28M | Nov 21, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $5.04M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $4.80M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $4.97M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $4.78M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $4.40M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $3.98M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $3.82M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $3.52M | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $2.91M | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | $4.72M | Nov 21, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $2.44M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $5.88M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $5.54M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $1.15M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $2.89M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $4.91M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $5.48M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $608.7K | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $5.74M | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | $2.06M | Nov 21, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.53M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $1.92M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $3.25M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $1.50M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $5.53M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $711.4K | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $960.3K | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $680.5K | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $922.3K | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | $643.4K | Nov 21, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $102.75M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $94.68M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $89.34M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $86.19M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $74.37M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $66.07M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $67.51M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $63.55M | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $56.61M | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | $51.07M | Nov 21, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $72.15M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $71.19M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $66.36M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $63.60M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $62.37M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $56.66M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $56.59M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $53.08M | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $48.86M | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | $44.53M | Nov 21, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $4.78M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $4.78M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $4.78M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $4.78M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $0 | Nov 15, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $52.27M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $53.77M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $51.00M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $50.72M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $46.97M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $42.47M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $44.99M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $41.96M | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | $37.08M | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | $33.66M | Nov 21, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $7.25M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $4.95M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $5.41M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $5.33M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $7.68M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $6.40M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $5.86M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $4.16M | Nov 13, 2019 |
| FY2019 | Aug 31, 2017 | $6.36M | Nov 13, 2019 |
| FY2018 | Aug 31, 2016 | $3.40M | Nov 13, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 0 | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | 0 | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | 0 | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | 0 | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | 0 | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | 0 | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | 0 | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | 0 | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | 0 | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | 0 | Nov 21, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 0 | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | 0 | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | 0 | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | 0 | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | 0 | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | 0 | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | 0 | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | 0 | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | 0 | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | 0 | Nov 21, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | 9.48M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | 9.47M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | 9.42M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | 9.23M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | 9.18M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | 9.10M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | 9.09M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | 9.08M | Nov 13, 2019 |
| FY2018 | Aug 31, 2017 | 4.54M | Nov 13, 2018 |
| FY2017 | Aug 31, 2016 | 4.53M | Nov 21, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.52M | Nov 20, 2025 |
| FY2025 | Aug 31, 2024 | $2.64M | Nov 20, 2025 |
| FY2024 | Aug 31, 2023 | $2.62M | Nov 19, 2024 |
| FY2023 | Aug 31, 2022 | $2.58M | Nov 21, 2023 |
| FY2022 | Aug 31, 2021 | $1.78M | Nov 15, 2022 |
| FY2021 | Aug 31, 2020 | $1.18M | Nov 19, 2021 |
| FY2020 | Aug 31, 2019 | $2.18M | Nov 13, 2020 |
| FY2019 | Aug 31, 2018 | $1.82M | Nov 13, 2019 |